Cognition Disorders in Old Age
26
7
10
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 26 trials
100.0%
+13.5% vs benchmark
4%
1 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (26)
Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults
Effects of Exercise Snacking on Physical Fitness, Cognition, and Pain in Institutionalized Older Adults
Real-world Clinical Response to Trazodone in Italy, Poland, and Romania
Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients
The Effect of Blueberry Supplementation on Cognitive Functioning in Older Adults
LSVT Big and Dual Task Training in Cognitive Impaired Patients
Neuropsychological Assessment Of The Oldest-Old Population.(NEUROPSIC-GR)
Probiotics in Mild Alzheimer's Disease
Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Brain Health Virtual Reality Study
The "Motoric Cognitive Risk" Syndrome in the Canadian Population
The "Motoric Cognitive Risk" Syndrome in the Quebec Population
Cognitive and Neural Assessment Platform and Localized Norm for Macau Older Adults.
Effects of Wearable Sensor-based Interactive Cognitive-motor Training in Older Adults.
Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years?
A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults
A Comprehensive ONline Program for Cognitive Enhancement, Reassurance and Training
A Feasibility Trial and Protocol for Remote Cognitive Training Developed for Use in a Cognitively Healthy Adult Population During the COVID-19 Pandemic
Prefrontal Cortex Dynamics of the Elderly During a Cognitive Stimulation Programme